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Response to treatmentAbstract Purpose: Nocturnal enuresis is defined as the involuntary voiding of urine in bed
beyond the age at which bladder control is normally obtained. Previous studies have suggested a
high rate of obesity in children with nocturnal enuresis. We evaluated this hypothesis and investi-
gated the correlation between body mass index and the efficacy of treatment.
Subjects and methods: This was a prospective–longitudinal study done on 180 children with pri-
mary mono symptomatic nocturnal enuresis. Urinary diary data and body mass index percentile
were determined. Response to the treatment was evaluated statistically and correlated with body
mass index percentile. Response to different modalities of the treatment were also statistically eval-
uated separately and correlated with the BMI. The statistical test used was ANOVA F-test.
Results: 22.7% of our patients with nocturnal enuresis were either overweight or obese (13.9%
and 7.8% respectively) according to the Egyptian national growth charts. Therefore, the prevalence
of overweight and obesity is not higher in children with nocturnal enuresis as compared to the over-
all prevalence in normal Egyptian children (14%). But when we adjusted these values according to
the social class of our patients, the prevalence of obesity was higher than normal for children of low
socioeconomic status.
There was no significant correlation between response to standard pediatric urological interven-
tions (behavioral therapy, alarm therapy, imipramine, desmopressin, oxybutynin and tolterodine)
and the BMI of our patients. Also, there was no significant difference in the response or relapse
rates to the different modalities of therapies in the groups of patients with different BMI.
Conclusions: Obesity correlates with high BMI in lower socioeconomic classes, but does not cor-
relate with efficacy of the treatment in children with nocturnal enuresis.
 2016 Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).and the
2 S.S. Zahra1. Introduction
Primary mono symptomatic nocturnal enuresis (PMNE) is one
of the most common developmental problems in children
which affects up to 20% of children at five years of age and
nearly 1% of young adults [1]. It is defined as involuntary uri-
nation while asleep after the age at which bladder control usu-
ally occurs [2]. Mono symptomatic enuresis is defined as
enuresis in children without any other urinary tract symptoms
and without a history of bladder dysfunction [2].
Obesity is increasing at an alarming rate throughout the
world. Obesity is a condition of excess body fat often associ-
ated with a large number of debilitating and life-threatening
disorders. Obese children are at a higher risk for asthma and
obstructive sleep apnea during childhood, as well as hyperten-
sion, diabetes, cardiovascular disease, gall bladder disease and
osteoarthritis in adulthood [3,4]. Overweight children have an
increased risk of being overweight as adults [3].
A good understanding of the association between obesity
and socioeconomic status (SES) has many important public
health and policy implications. In the developed countries
there is a strong inverse relationship between obesity and
SES. While in the developing societies a strong direct relation-
ship exists between SES and obesity among men, women and
children [5].
Previous studies suggested a high rate of obesity in children
with various forms of dysfunctional voiding, especially noctur-
nal enuresis [6]. However, there are few data regarding whether
obese children with nocturnal enuresis are more or less likely
to respond to the treatment. In a study done by Ahmet et al.
[7] a better response to the standard treatment in patients with
a BMI below the 85th percentile was seen. They speculated
that the lower success rates for the treatment in patients with
high BMI suggest not only that there is an association, but also
that obesity and incontinence may well share a common
etiology.
In the current study, we investigated the prevalence of obe-
sity among Egyptian children with primary mono symptomatic
nocturnal enuresis. And we investigated the correlation
between BMI and efficacy of the treatment. We also correlated
the BMI to the response and relapse rates of the different stan-
dard pediatric urological interventions used for the treatment
of enuresis in an attempt to identify the best modality of ther-
apy that can be used for the treatment of obese or overweight
enuretic children in Egypt.
2. Patients and methods
This was a prospective–longitudinal study. We evaluated 400
children (age ranges from 5–16 years) chosen randomly from
our Child and Adolescence Psychiatry Clinic, Children Hospi-
tal, Ain Shams University who had a diagnosis of primary
mono symptomatic nocturnal enuresis (PMNE) according to
the Standardization Committee of the International Children’s
Continence Society [2] in the period between July 2012 and
July 2014.
One hundred and eighty patients met our criteria. Eligible
patients had significant nocturnal enuresis (non diurnal) with-
out any other urinary tract symptoms and without a history of
bladder dysfunction with wetting frequency of 3 or more
nights per week, for at least 2 weeks of observation.Please cite this article in press as: Zahra SS, A prospective longitudinal study to estima
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from the study; diurnal enuresis, urinary tract infection, polyu-
ric disorders (diabetes mellitus or diabetes insipidus), abnor-
mal urine analysis, urinary tract abnormality, significant
hydronephrosis or reflux, history of renal disease, hypertension
or genitourinary abnormality, neurological disease, mental
retardation or psychological disease. Those with secondary
enuresis were, also, excluded (i.e. children who develop enure-
sis after a dry period of six months or more [2]).
3. Methodology
Each patient in this study was subjected to the following; Full
history was taken from all patients, including; demographic
data, presence of organic or psychological diseases, family his-
tory of similar cases, andprevious treatment for enuresis which
was received. Also assessment of the socioeconomic status of
the patients was done.
Clinical examination including; body measurements, physi-
cal examination and neurological examination.
Weight (Wt): The body weight was measured using Seca
scale and recorded to the nearest 0.1 kg. The measures were
converted into percentiles and were entered separately to the
Egyptian growth charts for age and sex [8].
Height (Ht): The standing height was measured using sta-
diometer to the nearest centimeter. The measures were con-
verted into percentiles and were entered separately to the
Egyptian growth charts for age and sex [8].
Body Mass Index (BMI): Body mass index was calculated
as weight in kilograms divided by the square of height in
meters (Wt (kg)/Ht (m2)). Then, it was plotted by age on a gen-
der specific Egyptian growth chart [8] to determine the child’s
category, which may be one of the following four categories
[9]:
 Normal weight: between the 5th and the 85th percentiles.
 Overweight: between the 85th and 95th percentiles.
 Obese: higher than 95th percentile.
 Underweight: less than 5th percentile.
Investigations: Urine analysis (for all cases): To exclude
presence of pyuria, glucosuria and diabetes insipidus.
Scales: The Stanford-Binet Intelligence scale [10] was used
for all the participating children to determine intelligence quo-
tient or IQ which is simply the ratio of mental age (MA) to
chronological age (CA) multiplied by 100 (IQ =MA/
CA  100). The Stanford–Binet Intelligence Scale consists of
15 subsets. The subsets are grouped into 4 broad areas verbal
reasoning, abstract/visual reasoning, quantitative reasoning
and short term memory and a composite score is derived from
the area scores.
The Socioeconomic Status Scale for health research in
Egypt-the new version [11] was performed for all patients
and their families. This scale was developed and validated
by Fahmy and El-Sherbini [12] and updated and re-
validated in 2012. The new socioeconomic status scale has
7 domains (education and culture, occupation, family, family
possessions, economic, home sanitation and health care) with
a total score of 84, with a higher score indicating better SES.
Socioeconomic level is classified into very low, low, middle
and high levels depending on the quartiles of the score
calculated.te the prevalence of obesity in Egyptian children with nocturnal enuresis and the
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apy was given to all children. These behavioral instructions
included increasing early daytime fluids, timed frequent void-
ing, reducing fluid intake in the evening and voiding before
bed [13]. Voiding diaries were used for the evaluation of treat-
ment progress (number of accidents, nocturia, presence of uri-
nary symptoms or constipation if any).
A written consent was obtained from the parents of all the
children participating in the study and approval from the Ain
Shams University Ethics committee was obtained. Also, the
work has been carried out in accordance with the code of
Ethics of the World Medical Association (Declaration of
Helsinki) for the experiments involving humans.
The choice of treatment modality prescribed for each
patient was chosen randomly using a basic numbered ball tech-
nique. Depending on the treatment modalities patients were
using, children were divided into six groups. The number of
patients included in each group was predecided (depending
on the medication availability in our clinic).
Group 1: (70 patients-behavioral therapy group) children
were on behavioral therapy as the only modality of therapy.
Group 2: (20 patients-desmopressin group) children in this
group were on DDAVP tablets (desmopressin tablets 0.2 mg
MinirinTM, Ferring International Centre, Switzerland) once
daily before bedtime in addition to behavioral instructions.
Group 3: (20 patients-tofranil group) they were on com-
bined imipramine, the antidepressant (TofranilTM tablets
25 mg) taken orally one hour before bed-time and behavioral
therapy.
Group 4: (20 patients-uripan group) they were on combined
oxybutynin-nonselective anticholinergic (UripanTM syrup 5 mg)
taken orally one hour before bed-time and behavioral therapy.
Group 5: (20 patients-tolterodine group) they were on com-
bined TolterodineTM-selective anticholinergic (tablets 2 mg)
taken orally one hour before bed-time and behavioral therapy.
Group 6: (30 patients-alarm group) These patients used Wet
Stop PALCOTM (wet-stop Alarm; Palco Laboratories, USA).
This is an enuretic alarm, details on the use of the alarm were
given to the parent in addition to behavioral instruction.
Follow up visits for all groups were scheduled every 2 weeks
for 6 months: To ensure adherence to behavioral instructions
and drug or alarm therapy, to record any adverse effect, and
to analyze the progress of the patients.
The main variable for analysis was the average number of
wet nights per week calculated over a defined period of
24 weeks.
Treatment outcomes were defined as follows [14]: ‘‘Complete
responders” were patients with 1 or less wet night per week in
the last 2 weeks of the treatment. ‘‘Partial responders” were
those with more than 1 wet night per week but greater than
50% reduction in the number of wet nights compared with
the pre treatment period. ‘‘Non-responders” had less than
50% reduction in wetting frequency in the last 2 weeks of
the treatment. Non-compliant patients and non-responders
were considered together as ‘‘treatment failure”.
Patients were followed for 12 weeks after cessation of the
treatment. ‘‘Relapsers” were defined as reappearance of >1
wet night per week for complete responders or >50% of the
pretreatment wetting frequency for partial responders. ‘‘Early
relapsers” and ‘‘late relapsers” were defined as those who
relapsed in the first 4 weeks and next 4 weeks of the post-
treatment observation period, respectively.Please cite this article in press as: Zahra SS, A prospective longitudinal study to estima
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The collected data were revised, coded, tabulated and intro-
duced to Statistical package for Social Science (SPSS 15.0.1
for windows; SPSS Inc, Chicago, IL, 2001). Data were pre-
sented and suitable analysis was done according to the type
of data obtained for each parameter.
For the descriptive statistical analysis of the subjects’ demo-
graphic data (mean, standard deviation (±SD) and range for
parametric numerical data, while median was used for non
parametric numerical data and frequency and percentage of
non-numerical data) we used the Student’s t-test to assess the
statistical significance of the difference between two study
group means. Mann–Whitney Test (U test) was used to assess
the statistical significance of the difference of a non parametric
variable between two study groups.
For the analytical statistical analysis the ANOVA test was
used to assess the statistical significance of the difference
between more than two study group means.
4. Results
We evaluated 180 children (89 girls [49.4%] and 91Boys
[50.6%]) with PMNE. Mean patient age was 9.12 ± 2.56 years
ranging between 5 and 16 years. Nine patients (5%) were
underweight, 132 patients (73.3%) were of normal weight, 25
patients (13.9%) were overweight and 14 patients (7.8%) were
obese. All the patients had significant enuresis prior to the
treatment. The mean number of wet nights per week was 6.1,
6.3, 6.7 and 5.8 in the underweight, normal weight, overweight
and obese patients respectively.
There were no statistically significant differences based on
age, gender, family history, number of wet nights per week,
social class, or the treatment modalities between the BMI
groups Table 1.
There was no statistically significant difference in the
response to treatment or relapse rates in children with different
BMI. However, there were minor differences (not reaching sta-
tistically significant values); for example a lower incidence of
complete response was noted in the overweight patients. On
the other hand, relapse rates (early and late) were more com-
mon in the underweight patients Table 2.
This study also showed that there was no statistically signif-
icant difference between the different groups of patients
(divided according to the modality of therapy they were receiv-
ing) and the patients’ BMI. However, there were some differ-
ences in the response pattern of each group.
In group 1 (behavioral therapy only); overweight patients
were (18.6%) of the total number of patients, this is slightly
more than the general percentages. They also show lower inci-
dence of complete responders (7.7%) and higher incidence of
non-responders (30.8%). In this group also obese patient
showed a high incidence of relapse (40%). It is worth mention-
ing that this group compromised the largest percentage of
patients (38.9%) Table 3.
In group 2 (desmopressin); there was no significant differ-
ence as regards response although the overweight patients
showed no complete response but were divided between the
partial and no response categories. The relapse was generally
higher in this group than other groups reaching 75% between
early and late relapse Table 4.te the prevalence of obesity in Egyptian children with nocturnal enuresis and the
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Table 1 Statistical comparison of patient characteristics with respect to the BMI.
Variable BMI groups X2 P
Underweight
(N= 9)
Normal
(N= 132)
Overweight
(N= 25)
Obese (N= 14)
Age in years 8.6 ± 2.7 (5–12) 9.4 ± 2.4 (5–16) 8.8 ± 3.2 (5–14) 8.2 ± 2.5 (6–
15)
1.522** .211
Sex Male 4
44.4%
69
52.3%
10
40.0%
6
42.9%
1.648 .649
Female 5
55.6%
63
47.7%
15
60.0%
8
57.1%
Family history Positive 4
66.7%
57
73.1%
6
66.7%
7
100.0%
2.913 .405
Negative 2
33.3%
21
26.9%
3
33.3%
0
0.0%
Number of wet nights per week prior to
therapy
6.1 ± 1.5 (3–7) 6.3 ± 1.4 (3–7) 6.7 ± .8 (3–7) 5.8 ± 1.9 (3–7) 1.46** .227
SES scale 14–28 16–30 18–29 20–30
Treatment
type
Behavioral therapy 4
44.4%
48
36.4%
13
52.0%
5
35.7%
13.917 .532
Desmopressin
therapy
2
22.2%
15
11.4%
2
8.0%
1
7.1%
Tofranil therapy 1
11.1%
17
12.9%
1
4.0%
1
7.1%
Uripan therapy 0
0.0%
17
12.9%
3
12.0%
0
0.0%
Tolterodine therapy 2
22.2%
14
10.6%
1
4.0%
3
21.4%
On alarm 0
0.0%
21
15.9%
5
20.0%
4
28.6%
ANOVA (F test).
Table 2 Results of treatment in children with nocturnal enuresis with respect to the BMI.
Variable BMI groups X2 P
Underweight (N= 9) Normal (N= 132) Overweight (N= 25) Obese (N= 14)
Response Non-responder 0
0.0%
23
17.4%
5
20.0%
1
7.1%
10.683 .099
Partial response 4
44.4%
38
28.8%
12
48.0%
2
14.3%
Complete response 5
55.6%
71
53.8%
8
32.0%
11
78.6%
Relapse No relapse 6
66.7%
92
77.3%
18
81.8%
11
78.6%
1.237 .975
Early relapse 2
22.2%
16
13.4%
3
13.6%
2
14.3%
Late relapse 1
11.1%
11
9.2%
1
4.5%
1
7.1%
ANOVA (F test).
4 S.S. ZahraGroup 3 (tofranil); most patients in this group were com-
plete responders (70%) with low incidence of relapse (15%
early and 5% late relapse) Table 5.
Group 4 (uripan); in this group there were neither under-
weight nor obese patients. Moreover, most overweight patients
showed partial response to this particular modality of therapy
(66% of overweight patients) associated with high incidence of
late relapse (33% of overweight patients) Table 6.
Group 5 (tolterodine); obese patients (15%) in this group
were more than the general percentages Table 7.Please cite this article in press as: Zahra SS, A prospective longitudinal study to estima
association between body mass index and response to therapy, Egypt J Med Hum GGroup 6 (alarm); this group shows very high incidence of
complete responders in all BMI groups (87% of the patients).
There was also no relapse seen in this particular group Table 8.
5. Discussion
According to our study results, the prevalence of overweight
and obesity (13.9% and 7.8%, respectively) is not higher in
children with nocturnal enuresis than their prevalence in the
normal Egyptian population. The prevalence of overweightte the prevalence of obesity in Egyptian children with nocturnal enuresis and the
enet (2016), http://dx.doi.org/10.1016/j.ejmhg.2016.04.008
Table 3 Results of treatment in children of group 1 (receiving behavioral therapy only) with respect to the BMI.
Variable BMI groups X2 P
Underweight (n= 4) Normal (n= 48) Overweight (n= 13) Obese (n= 5)
Response Non-responder 0
0.0%
12
25.0%
4
30.8%
0
0.0%
7.568 .271
Partial response 2
50.0%
23
47.9%
8
61.5%
2
40.0%
Complete response 2
50.0%
13
27.1%
1
7.7%
3
60.0%
Relapse No relapse 4
100.0%
31
77.5%
9
81.8%
3
60.0%
4.207 .649
Early relapse 0
0.0%
7
17.5%
2
18.2%
1
20.0%
Late relapse 0
0.0%
2
5.0%
0
0.0%
1
20.0%
ANOVA (F test).
Table 4 Results of treatment in children of group 2 (receiving desmopressin and behavioral therapy) with respect to the BMI.
Variable BMI groups X2 P
Underweight (N= 2) Normal (N= 15) Overweight (N= 2) Obese (N= 1)
Response Non-responder 0
0.0%
5
33.3%
1
50.0%
0
0.0%
4.215 .648
Partial response 1
50.0%
3
20.0%
1
50.0%
0
0.0%
Complete response 1
50.0%
7
46.7%
0
0.0%
1
100.0%
Relapse No relapse 0
0.0%
5
50.0%
0
0.0%
0
0.0%
6.020 .421
Early relapse 1
50.0%
2
20.0%
1
100.0%
1
100.0%
Late relapse 1
50.0%
3
30.0%
0
0.0%
0
0.0%
ANOVA (F test).
Table 5 Results of treatment in children of group 3 (receiving imipramine and behavioral therapy) with respect to the BMI.
Variable BMI groups X2 P
Underweight (N= 1) Normal (N= 17) Overweight (N= 1) Obese (N= 1)
Comment at 8 weeks Non-responder 0
0.0%
1
5.9%
0
0.0%
0
0.0%
1.513 .959
Partial response 0
0.0%
5
29.4%
0
0.0%
0
0.0%
Complete response 1
100.0%
11
64.7%
1
100.0%
1
100.0%
Relapse No relapse 0
0.0%
14
82.4%
1
100.0%
1
100.0%
6.324 .388
Early relapse 1
100.0%
2
11.8%
0
0.0%
0
0.0%
Late relapse 0
0.0%
1
5.9%
0
0.0%
0
0.0%
ANOVA (F test).
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Table 6 Results of treatment in children of group 4 (receiving
oxybutynin and behavioral therapy) with respect to the BMI.
Variable BMI X2 P
Normal
(n= 17)
Overweight
(n= 3)
Comment
at 8 weeks
Non-
responder
1
5.9%
0
0.0%
3.305 .192
Partial
response
3
17.6%
2
66.7%
Complete
response
13
76.5%
1
33.3%
Relapse No relapse 12
70.6%
2
66.7%
.672 .715
Early
relapse
2
11.8%
0
0.0%
Late
relapse
3
17.6%
1
33.3%
ANOVA (F test).
Table 7 Results of treatment in children of group 5 (receiving
tolterodine and behavioral therapy) with respect to the BMI.
Variable BMI X2 P
Normal
(n= 17)
Overweight
(n= 3)
Comment
at 8 weeks
Non-
responder
1
5.9%
0
0.0%
3.305 .192
Partial
response
3
17.6%
2
66.7%
Complete
response
13
76.5%
1
33.3%
Relapse No relapse 12
70.6%
2
66.7%
.672 .715
Early
relapse
2
11.8%
0
0.0%
Late
relapse
3
17.6%
1
33.3%
ANOVA (F test).
6 S.S. Zahrain Egypt according to the WHO is 14% of normal children
[15].
An Egyptian study made by Badawi et al. [16] showed that
the prevalence of overweight and obesity was 17.7% and
13.5% respectively in normal Egyptian children of different
socioeconomic status.Table 8 Results of treatment in children of group 6 (on alarm and
BMI groups
Normal (N= 21)
Comment at 8 weeks Non-responder 3
14.3%
Complete response 18
85.7%
Relapse No relapse 21
100.0%
5
100.0%
ANOVA (F test).
Please cite this article in press as: Zahra SS, A prospective longitudinal study to estima
association between body mass index and response to therapy, Egypt J Med Hum GThe result of almost similar prevalence of overweight and
obesity among both enuretic and normal children comes in
concordance with another study made by Burgu et al. [17].
But, contrary to our results Bakry et al. [18] reported a positive
statistically significant relationship between over-weight and
nocturnal enuresis in Egyptian children aged 4–12 years.
However, we must draw attention that although our results
show a similarity in the prevalence of overweight and obesity
between children with nocturnal enuresis and normal children
in the overall general Egyptian population, the prevalence of
overweight and obesity in the studied enuretic children is actu-
ally higher than normal for children of low socioeconomic sta-
tus attending public schools from whom our study population
was derived. Measure of the socioeconomic status done for our
patients (made in the beginning of the study) showed that all
included patients fell in the very low and low socioeconomic
class category. Included patients were gathered from the atten-
dee of the Child and Adolescent Psychiatry Clinic, Children
hospital, Ain Shams University (where the study was per-
formed) which is a governmental nonprofit institute providing
free service for mostly under privileged patients attending gov-
ernmental schools. This explains why our patients, exclusively,
were in the lower socioeconomic class.
Confirming the hypothesis that obesity is less common
among children of low socioeconomic class, is a study medi-
ated by Hafez et al. [19] which showed a prevalence of over-
weight and obesity of 11% and 3.8% respectively, among
healthy underprivileged children of governmental school in
Cairo. On the other hand higher values were detected among
children of private schools with percentage values of 21%
and 12.9% for overweight and obesity, respectively.
Moreover, a review of 144 published studies about the rela-
tionship between socioeconomic status (SES) and obesity
reveals a strong direct relationship between SES and obesity
among men, women, and children in the developing countries.
They suggested that parents with better economic means in the
developing countries seem to indulge themselves and their chil-
dren with more food [20].
Therefore if we made consideration for the socioeconomic
status of our patients, then we may suggest that the prevalence
of overweight and obesity is higher in our enuretic patients
than the normal Egyptian population in this particular socioe-
conomic class.
The finding of higher prevalence of obesity among children
with enuresis is supported by a study done by Erdem et al. [6]
which noted that elimination disorders especially nocturnal
enuresis were correlated with higher BMI.
Obese children may have hormonal differences, dietary dif-
ferences and even personality/behavioral differences comparedbehavioral therapy) with respect to the BMI.
X2 P
Overweight (N= 5) Obese (N= 4)
0
0.0%
1
25.0%
1.257 .533
5
100.0%
3
75.0%
4
100.0%
– –
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the increased rate of incontinence.
Sleep disordered breathing, a condition increasingly recog-
nized in obese children [21] may explain some of the associa-
tion between nocturnal enuresis and obesity. It has been
observed that children with sleep disordered breathing have
an increased incidence of nocturnal enuresis [22].
Moreover, there is the work done by Esposito et al. [23] to
evaluate the presence of sleep disturbances in 190 children with
affected PNE and 766 typically developing children. In this
study they evaluated sleep habits and disturbances by Sleep
Disturbances Scale for Children (SDSC) questionnaire filled
by the mothers. The questionnaire consisting of six subscales:
Disorders in Initiating and Maintaining Sleep (DIMS), Sleep
Breathing Disorders (SBD), Disorders of Arousal (DA),
Sleep–Wake Transition Disorders (SWTD), Disorders of
Excessive Somnolence (DOES), and Nocturnal Hyperhidrosis
(SHY). The result of the study showed that PNE children show
a higher prevalence of all sleep disturbances. Therefore it was
concluded that, PNE tends to alter sleep architecture and
could be a risk factor or a consequence for the development
of sleep disorders.
What is equally likely in our opinion is that parenting style
in obese children might be counterproductive for treating
incontinence. Rhee et al. [24] reported that a permissive,
neglectful or restrictive parenting style increases the risk of
obesity. These parenting styles could certainly be a causative
factor for voiding problems as well.
In our study we did not find a statistically significant correla-
tion between the responses to the different modalities of the
treatment in patients with different BMI. Although a slight
lower incidence of complete response was noted in the over-
weight patients, we searched the literature for studies that corre-
late the BMI of patients with nocturnal enuresis with the
response to treatment. Few studies were found that address this
particular issue. For example a study done by Ahmet et al. [7]
found a better response to the standard treatment in patients
with a BMI below the 85th percentile. They speculated that
the lower success rates for the treatment in patients with high
BMI suggest not only that there is an association, but also that
obesity and incontinence may well share a common etiology.
For example obesity has been shown to be related to hor-
monal abnormalities in some children [4], and nocturnal enure-
sis may be related to an abnormality of antidiuretic hormone
secretion [25]. Hence, a pituitary or other central nervous sys-
tem abnormality could be the cause of both conditions.
Alternatively, a diet high in carbohydrates and fats and low
in fiber, along with a sedentary lifestyle is likely to lead to obe-
sity, as well as constipation and possible postponement of
voiding [26].
When we correlated the BMI of our patients with the
response and the relapse rates to the different modalities of
the treatment used we found that there was no statistically sig-
nificant difference between them. Therefore, any of the stan-
dard regimens used for the treatment of nocturnal enuresis
can be used regardless the BMI of the patient.
6. Conclusions
In this study an association between obesity and an increased
incidence of nocturnal enuresis was not confirmed in EgyptianPlease cite this article in press as: Zahra SS, A prospective longitudinal study to estima
association between body mass index and response to therapy, Egypt J Med Hum Gchildren, but it is strongly suggested in patients with low
socioeconomic status. In addition, we found no obvious corre-
lation between BMI and the efficacy of treatment, nor did we
find a correlation between BMI and the different modalities of
therapy.
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